Barclays’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
10,567
-37,462
| -78% | -$14.2K | ﹤0.01% | 4225 |
|
|
2025
Q1 | $31K | Sell |
48,029
-17,093
| -26% | -$11K | ﹤0.01% | 3986 |
|
|
2024
Q4 | $109K | Buy |
65,122
+5,620
| +9% | +$9.41K | ﹤0.01% | 3773 |
|
|
2024
Q3 | $107K | Buy |
59,502
+42,185
| +244% | +$75.9K | ﹤0.01% | 3728 |
|
|
2024
Q2 | $105K | Sell |
17,317
-11,318
| -40% | -$68.6K | ﹤0.01% | 3351 |
|
|
2024
Q1 | $319K | Sell |
28,635
-16,002
| -36% | -$178K | ﹤0.01% | 3083 |
|
|
2023
Q4 | $664K | Buy |
44,637
+17,673
| +66% | +$263K | ﹤0.01% | 2847 |
|
|
2023
Q3 | $129K | Buy |
26,964
+9,796
| +57% | +$46.9K | ﹤0.01% | 3227 |
|
|
2023
Q2 | $130K | Buy |
17,168
+1,621
| +10% | +$12.3K | ﹤0.01% | 3293 |
|
|
2023
Q1 | $70K | Buy |
15,547
+4,019
| +35% | +$18.1K | ﹤0.01% | 3683 |
|
|
2022
Q4 | $130K | Buy |
11,528
+4,851
| +73% | +$54.7K | ﹤0.01% | 3318 |
|
|
2022
Q3 | $64K | Buy |
6,677
+2,464
| +58% | +$23.6K | ﹤0.01% | 3576 |
|
|
2022
Q2 | $34K | Sell |
4,213
-494
| -10% | -$3.99K | ﹤0.01% | 3882 |
|
|
2022
Q1 | $80K | Buy |
+4,707
| New | +$80K | ﹤0.01% | 3776 |
|